InvestorsHub Logo
Followers 138
Posts 23018
Boards Moderated 0
Alias Born 04/08/2004

Re: Investor2014 post# 278529

Sunday, 10/25/2020 2:46:45 PM

Sunday, October 25, 2020 2:46:45 PM

Post# of 460238
For prior late breaking presentation, did Anavex ever preannounce clinically meaningful, dose-dependent, and statistically significant improvements before the confersnce presentation.

https://www.anavex.com/anavex-life-sciences-announces-positive-results-from-proof-of-concept-controlled-phase-2-clinical-trial-evaluating-anavex2-73-blarcamesine-in-parkinsons-disease-dementia/

They sis NOT!!

This time:

“As the first double-blind trial of ANAVEX®2-73 (blarcamesine) in PDD, this proof-of-concept study provides extremely encouraging data.



GOD bless,
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News